• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重新审视非瓣膜性心房颤动结局中的性别差异:一项基于人群的队列研究。

Revisiting sex differences in outcomes in non-valvular atrial fibrillation: a population-based cohort study.

机构信息

Centre for Clinical Epidemiology, Lady Davis Institute for Medical Research, Jewish General Hospital, 3755 Côte Sainte-Catherine Road, Montreal, QC H3T 1E2, Canada.

Department of Neurology and Neurosurgery, McGill University, 3801 University Street, Montreal QC H3A 2B4, Canada.

出版信息

Eur Heart J. 2017 May 14;38(19):1473-1479. doi: 10.1093/eurheartj/ehw613.

DOI:10.1093/eurheartj/ehw613
PMID:28073863
Abstract

AIMS

In patients with non-valvular atrial fibrillation (NVAF), it is uncertain whether the higher risk of ischaemic stroke in women reported in some studies is due to residual confounding. We assessed this association using standard time-fixed and more accurate time-dependent adjustment for confounders.

METHODS AND RESULTS

Using the computerized databases of the Régie de l'assurance maladie du Québec (RAMQ), we identified a cohort of patients with NVAF during 2000-2009 and RAMQ medication coverage. Cox proportional hazards models were used to estimate the hazard ratio (HR) of ischaemic stroke, death, and bleeding, associated with sex, adjusting for time-fixed covariates at cohort entry. This was compared with adjustment for time-dependent covariates using an age and time-matched nested case-control analysis. The cohort included 147 622 patients. During a mean follow-up of 2.9 years 11 326 patients had a stroke (incidence rate 2.6 per 100 per year). Using time-fixed adjustment for confounders, women had a moderately higher risk of ischaemic stroke than men (HR 1.16 (Confidence interval (CI) 95% 1.11-1.21). Matching on age and using time-dependent adjustment for confounders, women were not at higher risk of stroke than men (Rate Ratio 1.01; 95% CI 0.97-1.05). Mortality and bleeding rates were lower in women compared with men in both analyses.

CONCLUSION

In NVAF, women were not at higher risk of thromboembolic events than men in our study. The small increased risk reported in previous studies may be related to residual confounding, in particular from insufficient control for age.

摘要

目的

在非瓣膜性心房颤动(NVAF)患者中,一些研究报告女性发生缺血性卒中的风险较高,其原因是否归因于残留混杂因素尚不确定。我们使用标准的时间固定调整和更准确的时间相关调整来评估这种关联。

方法和结果

利用魁北克省健康保险局(RAMQ)的计算机数据库,我们确定了 2000-2009 年 NVAF 患者队列和 RAMQ 药物覆盖范围。使用 Cox 比例风险模型来估计缺血性卒中、死亡和出血的风险比(HR),其与性别相关,在队列入组时调整时间固定协变量。将其与使用年龄和时间匹配嵌套病例对照分析进行的时间相关协变量调整进行比较。该队列包括 147622 名患者。在平均 2.9 年的随访中,有 11326 名患者发生了卒中(发生率为 2.6/100 人年)。使用时间固定调整混杂因素,女性缺血性卒中的风险略高于男性(HR 1.16(95%CI 95% 1.11-1.21))。在年龄匹配的情况下,并使用时间相关调整混杂因素,女性发生卒中的风险并不高于男性(率比 1.01;95%CI 0.97-1.05)。在这两种分析中,女性的死亡率和出血率均低于男性。

结论

在 NVAF 中,与男性相比,女性在我们的研究中没有更高的血栓栓塞事件风险。以前研究报告的风险略有增加可能与残留混杂因素有关,特别是与年龄控制不足有关。

相似文献

1
Revisiting sex differences in outcomes in non-valvular atrial fibrillation: a population-based cohort study.重新审视非瓣膜性心房颤动结局中的性别差异:一项基于人群的队列研究。
Eur Heart J. 2017 May 14;38(19):1473-1479. doi: 10.1093/eurheartj/ehw613.
2
Incidence, mortality, and sex differences of non-valvular atrial fibrillation: a population-based study.非瓣膜性心房颤动的发病率、死亡率及性别差异:一项基于人群的研究。
J Am Heart Assoc. 2014 Nov 3;3(6):e001402. doi: 10.1161/JAHA.114.001402.
3
Long-term vitamin K antagonists treatment patterns of Non-Valvular Atrial Fibrillation (NVAF): a population-based cohort study.非瓣膜性心房颤动(NVAF)的长期维生素K拮抗剂治疗模式:一项基于人群的队列研究。
BMC Cardiovasc Disord. 2016 May 10;16:84. doi: 10.1186/s12872-016-0269-4.
4
Impact of sex differences on outcomes in patients with non-valvular atrial fibrillation undergoing left atrial appendage closure: A single-center experience.非瓣膜性心房颤动患者行左心耳封堵术的性别差异对结局的影响:单中心经验。
Int J Med Sci. 2021 Mar 3;18(9):1990-1998. doi: 10.7150/ijms.53221. eCollection 2021.
5
Pattern of atrial fibrillation and risk of outcomes: the Loire Valley Atrial Fibrillation Project.房颤模式与结局风险:卢瓦尔河谷房颤项目。
Int J Cardiol. 2013 Sep 10;167(6):2682-7. doi: 10.1016/j.ijcard.2012.06.118. Epub 2012 Jul 15.
6
Is von Willebrand factor associated with stroke and death at mid-term in patients with non-valvular atrial fibrillation?非瓣膜性心房颤动患者中期卒中与死亡与血管性假性血友病因子相关吗?
Arch Cardiovasc Dis. 2018 May;111(5):357-369. doi: 10.1016/j.acvd.2017.08.004.
7
Long-term Thromboembolic Risk in Patients With Postoperative Atrial Fibrillation After Left-Sided Heart Valve Surgery.左侧心脏瓣膜手术后并发术后心房颤动患者的长期血栓栓塞风险。
JAMA Cardiol. 2019 Nov 1;4(11):1139-1147. doi: 10.1001/jamacardio.2019.3649.
8
Sex Differences in Dabigatran Use, Safety, And Effectiveness In a Population-Based Cohort of Patients With Atrial Fibrillation.在一个基于人群的房颤患者队列中达比加群使用、安全性及有效性方面的性别差异
Circ Cardiovasc Qual Outcomes. 2015 Nov;8(6):593-9. doi: 10.1161/CIRCOUTCOMES.114.001398. Epub 2015 Oct 27.
9
Female sex as a risk factor for thromboembolism and death in patients with incident atrial fibrillation. The prospective Danish Diet, Cancer and Health study.女性性别作为新发房颤患者血栓栓塞和死亡的危险因素。丹麦前瞻性饮食、癌症与健康研究。
Thromb Haemost. 2014 Oct;112(4):789-95. doi: 10.1160/TH14-06-0545. Epub 2014 Jul 24.
10
A comparison of the safety and effectiveness of dabigatran and warfarin in non-valvular atrial fibrillation patients in a large healthcare system.在大型医疗体系中比较达比加群酯和华法林在非瓣膜性心房颤动患者中的安全性和有效性。
Thromb Haemost. 2015 Nov 25;114(6):1290-8. doi: 10.1160/TH15-06-0453. Epub 2015 Oct 8.

引用本文的文献

1
Does the current apixaban dosing strategy adequately fit and ensure safety in Korean patients with atrial fibrillation?目前的阿哌沙班给药策略是否适合韩国房颤患者并确保其安全性?
Blood Res. 2025 Sep 8;60(1):50. doi: 10.1007/s44313-025-00103-4.
2
Emergency department visit for atrial fibrillation: sex differences in treatment and outcomes in the Global RE-LY AF Registry.因心房颤动就诊于急诊科:全球RE-LY AF注册研究中的治疗及结局的性别差异
Eur Heart J. 2024 Jul 9;45(26):2336-2340. doi: 10.1093/eurheartj/ehae319.
3
Chinese Guidelines for the Diagnosis and Management of Atrial Fibrillation.
《中国心房颤动诊断与治疗指南》
J Geriatr Cardiol. 2024 Mar 28;21(3):251-314. doi: 10.26599/1671-5411.2024.03.009.
4
Female "Paradox" in Atrial Fibrillation-Role of Left Truncation Due to Competing Risks.心房颤动中的女性“悖论”——竞争风险导致的左截断作用
Life (Basel). 2023 May 5;13(5):1132. doi: 10.3390/life13051132.
5
Gender Differences in Atrial Fibrillation: From the Thromboembolic Risk to the Anticoagulant Treatment Response.性别差异与心房颤动:从血栓栓塞风险到抗凝治疗反应。
Medicina (Kaunas). 2023 Jan 28;59(2):254. doi: 10.3390/medicina59020254.
6
Sex-Related Differences in Left Atrial Low-Voltage Areas According to CHADS-VA Scores among Patients with Atrial Fibrillation.房颤患者中根据CHADS-VA评分的左心房低电压区域的性别差异
J Clin Med. 2022 May 31;11(11):3111. doi: 10.3390/jcm11113111.
7
Efficacy of RCHADS-VA score for predicting thromboembolism in Thai patients with non-valvular atrial fibrillation.泰国非瓣膜性心房颤动患者 RCHADS-VA 评分预测血栓栓塞的有效性。
BMC Cardiovasc Disord. 2021 Nov 12;21(1):540. doi: 10.1186/s12872-021-02370-2.
8
Influence of gender on the clinical outcomes of Asian non-valvular atrial fibrillation patients: insights from the prospective multicentre COOL-AF registry.亚洲非瓣膜性心房颤动患者的临床结局受性别影响:来自前瞻性多中心 COOL-AF 注册研究的观察。
BMJ Open. 2021 May 6;11(5):e043862. doi: 10.1136/bmjopen-2020-043862.
9
Sex Difference in the Risk of Dementia in Patients with Atrial Fibrillation.心房颤动患者患痴呆症风险的性别差异
Diagnostics (Basel). 2021 Apr 23;11(5):760. doi: 10.3390/diagnostics11050760.
10
Adverse event rates associated with oral anticoagulant treatment early versus later after hospital discharge in older adults: a retrospective population-based cohort study.老年人出院后早期与晚期口服抗凝治疗相关的不良事件发生率:一项基于人群的回顾性队列研究。
CMAJ Open. 2021 Apr 16;9(2):E364-E375. doi: 10.9778/cmajo.20200138. Print 2021 Apr-Jun.